Challenges in the treatment of gastrointestinal tumours.
In the last 20 years there have been many breakthroughs in the treatment of gastrointestinal tumours. In this review we have considered the three most important subgroups of gastrointestinal tumours (colorectal, gastric and pancreatic cancer), focusing on the state-of-the-art treatments.
Labianca
R
R
Department of Oncology, Ospedali Riuniti, Bergamo, Italy. segroncologia@ospedaliriuniti.bergamo.it
Berardi
E
E
Malugani
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000628:therapy; D018450:Disease Progression; D005770:Gastrointestinal Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy